The SATVI Field Site laboratory has received verfication of their proficiency in PBMC isolation and Cryopreservation which was assessed by the Immunology Quality Assessment Contract Laboratory (IQA) at the Duke Human Vaccine Institute (HVC.
Researchers are the South African Tuberculosis Vaccine Initiative (SATVI) have acquired a Tecan Freedom EVO 150, to be used as a robotic liquid handling platform
We are inviting applications for a postdoctoral fellowship in systems immunology to conduct research on a newly funded project aimed at identifying common immune signatures and mechanisms in humans and animal models of TB. Closing Date 30 July 2016
The Laboratories of the South African Tuberculosis Vaccine Initiative have been approved to conduct tests in A5343, in support of Protocol A5343, A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid.